Showing results (371-380 of 569) with videos related to

Sort By:
Pageof 57
Cancer Research|April 12, 2015
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresJennifer Stone, Deborah J Thompson, Isabel Dos Santos Silva, et al.
Nature Cancer|December 30, 2022
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
Plos Genetics|July 28, 2010
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locusSimon N Stacey, Patrick Sulem, Carlo Zanon, et al.
The New England Journal of Medicine|January 20, 2021
A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Steven N Hart, Rohan Gnanaolivu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.
Iscience|February 24, 2026
Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancerAaron J Bernstein, Renske Keeman, Amber N Hurson, et al.
The Lancet. Oncology|January 18, 2021
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyErica L Mayer, Amylou C Dueck, Miguel Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerMaren Weischer, Børge G Nordestgaard, Paul Pharoah, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Pageof 57